Esempio: Heart Attack

Cerca studi clinici per: Narcotic Antagonists

Totale 1039 risultati

NCT02218736

Completato

Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a

Condizioni: ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
NCT04743570

Non ancora reclutando

Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis

Condizioni: Acute Pancreatitis
NCT03223896

Completato

Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray

Condizioni: Gambling; Opioid; Naloxone; Spray
NCT02792140

Completato

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

Condizioni: Neuroscience of Dreaming, Healthy
NCT04325802

Non ancora reclutando

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

Condizioni: Atopic Dermatitis; Pruritus; Pruritus Chronic; Dermatitis
NCT00399295

Completato

An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg

Condizioni: Analgesia
NCT01673594

Completato

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

Condizioni: ADHD; Stimulant-Induced Euphoria
NCT00398957

Completato

An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg

Condizioni: Analgesia
NCT02557984

Completato

Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity

Condizioni: Addiction
NCT03638440

Attivo, non reclutamento

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

Condizioni: Opioid Induced Constipation
NCT00142727

Terminato

Opioid Agonist and Antagonist Effects on Opioid Dependence

Condizioni: Opioid-Related Disorders
NCT04219046

Non ancora reclutando

Evaluation of Naloxegol in the Prevention of POI After Cystectomy

Condizioni: Bladder Cancer; Cystostomy; Complications
NCT02813356

Attivo, non reclutamento

Naloxegol US PMR CV Safety.

Condizioni: Opioid Induced Constipation
NCT03087708

Attivo, non reclutamento

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Condizioni: Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
NCT01367561

Completato

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

Condizioni: Healthy Males
NCT03278886

Completato

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

Condizioni: HIV Infection; Alcohol Use; Pain
NCT02362256

Completato

The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism

Condizioni: Opiate Addiction
NCT02813369

Reclutamento

Naloxegol Health Outcome Post Authorisation Safety Study

Condizioni: Opioid Induced Constipation
NCT00124839

Terminato

Naltrexone in Borderline Personality Disorder

Condizioni: Borderline Personality Disorder
NCT00460239

Completato

Buprenorphine's Dose Response Curve

Condizioni: Opioid-related Disorders
NCT04052139

Reclutamento

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin

Condizioni: Chronic Pain; Alcohol Use, Unspecified; HIV Infections
NCT02099591

Reclutamento

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients

Condizioni: Constipation, Signs and Symptoms, Digestive
NCT02403830

Completato

Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine

Condizioni: Coronary Artery Disease
NCT04757506

Completato

An Investigation of the Effects of Opioid Receptor Blockade on Changes in Self-esteem and Social Attention

Condizioni: Self Esteem
NCT04764630

Non ancora reclutando

Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone

Condizioni: Healthy Subjects; Opioid Antagonist; Pharmacokinetics